Seres Therapeutics, Inc. Financial Ratios — MCRB Stock

Profitability (USD)

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	-54.18	-92.46	- -	- -	- -	-42.83	-351.62	- -	- -	19.64
Return on Assets (%)	- -	-574.31	-27.97	-32.78	-37.41	-38.68	-63.83	-55.58	-37.5	-18.8	-71.1	-32.15	0.05	4.1
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.9
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-80.8
Gross Margin (%)	- -	- -	- -	- -	100	100	100	100	100	100	100	100	- -	-729.4
EBITDA Margin (%)	- -	- -	- -	- -	-407.21	-262.11	-326.96	-181.95	-245.53	-40.4	- -	- -	- -	-11,386.31
Operating Margin (%)	- -	- -	- -	- -	-426.53	-284.72	-354.77	-203.98	-265.33	-44.5	- -	- -	- -	-11,910.14
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	79.64	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	-420.74	-278.44	-350.03	-203.68	-268.33	-45.25	- -	- -	- -	721.93
Profit Margin (%)	- -	- -	- -	- -	-420.74	-278.44	-350.03	-203.68	-268.33	-45.25	- -	- -	- -	721.93
Net Income to Common Margin (%)	- -	- -	- -	- -	-420.74	-278.44	-350.03	-203.68	-268.33	-45.25	- -	- -	- -	721.93
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	12.54	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	-54.18	-92.46	- -	- -	- -	-42.83	-351.62	- -	- -	19.64

Credit (USD)

Credit Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	1	3	- -	- -	9	- -	45	41	49	163	199	92	83
ST Debt	- -	- -	1	- -	- -	- -	- -	4	6	7	4	6	9	10
LT Debt	- -	- -	1	- -	- -	9	- -	40	35	43	159	193	83	73
Total Debt/EBITDA	- -	-0.14	-0.17	- -	- -	-0.11	- -	-0.71	-0.5	-0.84	-0.94	-1.05	-0.79	-0.92
Net Debt/EBITDA	- -	0.14	7.5	1.37	0.62	0.43	0.93	0.64	1.12	2.65	0.65	0.14	0.27	0.51
Total Debt/EBIT	- -	-0.14	-0.17	- -	- -	-0.1	- -	-0.64	-0.46	-0.76	-0.9	-1.02	-0.76	-0.88
Net Debt/EBIT	- -	0.13	7.4	1.35	0.59	0.39	0.86	0.58	1.03	2.41	0.62	0.14	0.25	0.49
EBITDA to Interest Expense	- -	-142	-71.25	-97.53	-91.47	- -	- -	-125.06	-27.89	-20.12	-28.78	-76.52	- -	- -
EBITDA-CapEx/Interest Expense	- -	-146.14	-76.04	-105.39	-113.65	- -	- -	-127.06	-28.09	-23.41	-30.42	-79.75	- -	- -
EBIT to Interest Expense	- -	-144.1	-72.16	-98.84	-95.81	- -	- -	-140.21	-30.14	-22.16	-29.89	-79.05	- -	- -
Interest Expense	- -	- -	- -	1	1	- -	- -	1	3	3	6	2	- -	- -
Common Equity/Total Assets	- -	-523.11	-22.77	94.7	48.65	32.03	-39.88	-36.49	50.96	37.06	3.09	-12.51	9.86	32
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	14.81	- -	- -	20.14	32.39	1,470.21	- -	601.9	164.13
Long-Term Debt/Capital (%)	- -	-4.26	-5.38	- -	- -	12.9	- -	-1,137.81	16.33	23.57	91.44	125.51	78.7	57.06
Long-Term Debt/Total Assets (%)	- -	20.61	1.11	- -	- -	4.74	- -	30.45	10.26	12.01	45.45	53.88	59.34	52.52
Total Debt/Equity (%)	- -	-7.54	-9.37	- -	- -	14.81	- -	-92.67	23.33	37.42	1,507.84	-443.16	664.83	187.63
Total Debt/Capital (%)	- -	-8.15	-10.34	- -	- -	12.9	- -	-1,263.54	18.92	27.23	93.78	129.14	86.93	65.23
Total Debt/Total Assets (%)	- -	39.44	2.13	- -	- -	4.74	- -	33.81	11.89	13.87	46.62	55.43	65.55	60.04
Net Debt to Equity	- -	7.34	417.95	-36	-41.12	-59.45	178.62	83.76	-52.05	-118.14	-1,038.51	58.9	-223.4	-103.5
Net Debt/Capital (%)	- -	6.84	80.69	-56.24	-69.84	-107.4	64.11	58.95	-91.44	-21,698.18	-1,082.69	-101.77	-41.26	-56.21
EBITDA	-3	-6	-15	-54	-89	-84	-92	-63	-82	-59	-173	-189	-116	-90
EBITDA-CapEx	-3	-6	-16	-58	-110	-89	-94	-64	-82	-68	-183	-197	-116	-90
Operating Income (Loss)	-3	-6	-15	-55	-93	-91	-100	-70	-88	-64	-180	-195	-121	-94

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	- -	1.57	22.38	18.78	6.34	4.74	2.04	2.06	5.46	3.53	2.12	1.3	0.75	2.37
Current Ratio	- -	1.61	22.39	19.01	6.51	4.9	2.2	2.18	5.79	3.69	2.28	1.78	0.94	2.56
Quick Ratio	- -	1.57	22.38	18.78	6.34	4.74	2.04	2.1	5.67	3.53	2.12	1.3	0.86	2.4
CFO/Avg Current Liab	- -	-10.08	-3.36	-5.1	2.12	-2.43	-1.71	-1.74	-2.03	0.1	-2.73	-1.27	-2.12	0.04
Common Equity/Total Assets	- -	-523.11	-22.77	94.7	48.65	32.03	-39.88	-36.49	50.96	37.06	3.09	-12.51	9.86	32
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	14.81	- -	- -	20.14	32.39	1,470.21	- -	601.9	164.13
Long-Term Debt/Capital (%)	- -	-4.26	-5.38	- -	- -	12.9	- -	-1,137.81	16.33	23.57	91.44	125.51	78.7	57.06
Long-Term Debt/Total Assets (%)	- -	20.61	1.11	- -	- -	4.74	- -	30.45	10.26	12.01	45.45	53.88	59.34	52.52
Total Debt/Equity (%)	- -	-7.54	-9.37	- -	- -	14.81	- -	-92.67	23.33	37.42	1,507.84	-443.16	664.83	187.63
Total Debt/Capital (%)	- -	-8.15	-10.34	- -	- -	12.9	- -	-1,263.54	18.92	27.23	93.78	129.14	86.93	65.23
Total Debt/Total Assets (%)	- -	39.44	2.13	- -	- -	4.74	- -	33.81	11.89	13.87	46.62	55.43	65.55	60.04
CFO/Total Liabilities	- -	-40.19	-7.19	-354.98	31.37	-58.63	-37.3	-42.33	-55.66	2.99	-67.7	-29.09	-117.92	1.19
CFO/CapEx	-10.02	-30.58	-10.35	-9.36	2.04	-16.15	-32.45	-76.37	-158.39	0.7	-23.3	-14.72	-391.08	4.43
Altman's Z-Score	- -	-16.36	0.36	71.23	0.51	-0.67	-5.87	-5.06	5.78	0.19	-3.55	-5.08	-12	-10.92

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	38.66	5.95	30.88	- -	- -	- -	0.61
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	9.44	61.38	11.82	- -	- -	- -	597.92
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.24	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,531.87	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.81	-6.77	2.27
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	129.77	-53.95	160.66
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	437.26
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	597.92
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	30	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	4	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	25	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	1,371	400	411	185	242	2,241	765	701	189	144	142
- Cash & Cash Equivalents	- -	2	114	74	55	36	86	65	116	180	163	128	31	46
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	1	3	- -	- -	9	- -	45	41	49	163	199	92	83
Enterprise Value	- -	-1	-112	1,166	206	270	99	192	2,028	524	682	260	205	179
Total Capital	- -	-10	-24	205	133	70	-48	-4	216	181	173	154	105	127
Total Debt/Capital (%)	- -	-8.15	-10.34	- -	- -	12.9	- -	-1,263.54	18.92	27.23	93.78	129.14	86.93	65.23
Total Debt / EV	- -	-1.03	-0.02	- -	- -	0.03	- -	0.23	0.02	0.09	0.24	0.76	0.45	0.46
EV/Sales	- -	- -	- -	- -	9.48	8.42	3.51	5.56	61.05	3.62	- -	- -	- -	227.38
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	4.6	- -	- -	- -	- -	54.59	- -	- -	- -	160.61
EV/Free Cash Flow to Firm	- -	- -	- -	- -	3.11	- -	- -	- -	- -	27.34	- -	- -	- -	131.04
Diluted Market Cap	- -	- -	- -	826	394	410	184	195	1,955	764	605	179	129	132
Diluted Enterprise Value	- -	-1	-112	752	340	383	98	175	1,880	633	605	250	190	169
EV per Share	- -	- -	- -	596.85	102.23	133.3	48.47	54.73	443.46	114.04	109.01	38.49	23.65	18.77
TTM Sales	- -	- -	- -	- -	22	32	28	35	33	145	- -	- -	- -	1
TTM EBITDA	-3	-6	-15	-54	-89	-84	-92	-63	-82	-59	-173	-189	-116	-90
TTM Operating Income	-3	-6	-15	-55	-93	-91	-100	-70	-88	-64	-180	-195	-121	-94
TTM Cash Flow to Firm	-3	-5	-10	-40	45	-76	-63	-76	-91	10	-223	-115	-149	1
TTM Free Cash Flow to Firm	-3	-5	-9	-36	66	-71	-61	-75	-90	19	-213	-107	-148	1

Multiples (USD)

Valuation Multiples API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	-22.63	6.03	-5.79	-3.02	-2.59	-21.02	47	-2.76	-1.64	-0.87	96.41
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	-1	-112	1,166	206	270	99	192	2,028	524	682	260	205	179
Low Price	- -	- -	- -	500	161	177	90.4	40.4	50.4	108.2	50	18.2	10.8	6.53
EV/Sales	- -	- -	- -	- -	9.48	8.42	3.51	5.56	61.05	3.62	- -	- -	- -	227.38
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	949.53	23.14
Price/Earnings Average	- -	- -	- -	-15.89	-9.11	-5.02	-3.38	-3.58	-12.11	-21.46	-2.57	-4.48	1,066.56	22.54
Price/Earnings High	- -	- -	- -	-22.34	-15.66	-7.88	-4.67	-6.76	-34.47	-41.81	-4.1	-7.73	2,342.4	46.63
Price/Earnings Low	- -	- -	- -	-10.74	-3.5	-4.01	-1.86	-1.63	-2.26	-7.57	-1.08	-1.02	617.02	10.16
Price/Book Value	- -	- -	- -	6.68	3.01	6.78	-3.85	-5.01	12.82	5.82	65.03	-4.21	10.43	3.22
Price/Book Value Average	- -	- -	- -	7.04	6.37	7.41	-6.99	-6.45	7.08	10.73	69.12	-11.99	11.72	3.13
Price/Book Value High	- -	- -	- -	9.89	10.95	11.64	-9.67	-12.18	20.15	20.89	110.21	-20.68	25.73	6.48
Price/Book Value Low	- -	- -	- -	4.76	2.45	5.92	-3.85	-2.93	1.32	3.78	29.03	-2.74	6.78	1.41
Price/Tangible Book Value	- -	- -	- -	6.68	3.01	6.78	-3.85	-5.01	12.82	5.82	65.03	-4.21	10.43	3.22
Price/Tangible Book Value Average	- -	- -	- -	7.04	6.37	7.41	-6.99	-6.45	7.08	10.73	69.12	-11.99	11.72	3.13
Price/Tangible Book Value High	- -	- -	- -	9.89	10.95	11.64	-9.67	-12.18	20.15	20.89	110.21	-20.68	25.73	6.48
Price/Tangible Book Value Low	- -	- -	- -	4.76	2.45	5.92	-3.85	-2.93	1.32	3.78	29.03	-2.74	6.78	1.41
Price/Sales	- -	- -	- -	- -	18.12	12.78	6.52	5.66	58.85	5.27	- -	- -	- -	167.07
Price/Sales Average	- -	- -	- -	- -	38.35	13.98	11.82	7.29	32.49	9.71	- -	- -	- -	162.69
Price/Sales High	- -	- -	- -	- -	65.87	21.95	16.36	13.77	92.48	18.92	- -	- -	- -	336.62
Price/Sales Low	- -	- -	- -	- -	14.74	11.15	6.52	3.32	6.05	3.42	- -	- -	- -	73.32
Price/Cash Flow	- -	- -	- -	-20.22	8.98	-5.43	-2.93	-2.55	-20.88	114.22	-2.65	-1.53	-0.87	118.01
Price/Cash Flow Average	- -	- -	- -	-21.31	19.01	-5.94	-5.32	-3.29	-11.53	210.47	-2.81	-4.34	-0.98	114.92
Price/Cash Flow High	- -	- -	- -	-29.96	32.64	-9.33	-7.36	-6.21	-32.82	409.98	-4.48	-7.49	-2.14	237.77
Price/Cash Flow Low	- -	- -	- -	-14.4	7.3	-4.74	-2.93	-1.5	-2.15	74.18	-1.18	-0.99	-0.56	51.79
Price/Free Cash Flow Average	- -	- -	- -	-23.86	12.76	-6.33	-5.48	-3.33	-11.6	86.6	-2.94	-4.66	-0.98	93.88
Price/Free Cash Flow High	- -	- -	- -	-33.54	21.92	-9.95	-7.59	-6.29	-33.02	168.69	-4.68	-8.04	-2.15	194.24
Price/Free Cash Flow Low	- -	- -	- -	-16.13	4.9	-5.05	-3.02	-1.52	-2.16	30.52	-1.23	-1.06	-0.57	42.31
EV/Sales Average	- -	- -	- -	- -	36.33	13.18	8.84	8.44	34.98	8.83	- -	- -	- -	222.65
EV/Sales High	- -	- -	- -	- -	64.2	21.17	13.4	16.47	103.75	18.06	- -	- -	- -	410.27
EV/Sales Low	- -	- -	- -	- -	12.42	10.34	3.51	3.52	4.67	2.53	- -	- -	- -	126.24
EV/EBITDA Average	- -	0.14	7.5	-25.34	-8.92	-5.03	-2.7	-4.64	-14.25	-21.86	-4.3	-3.22	-1.92	-1.96
EV/EBITDA High	- -	0.14	7.5	-36.18	-15.77	-8.08	-4.1	-9.05	-42.25	-44.69	-6.86	-5.29	-3.59	-3.6
EV/EBITDA Low	- -	0.14	7.5	-16.68	-3.05	-3.95	-1.07	-1.93	-1.9	-6.26	-1.8	-1.03	-1.33	-1.11
EV/EBIT Average	- -	0.13	7.4	-25	-8.52	-4.63	-2.49	-4.14	-13.18	-19.84	-4.14	-3.12	-1.83	-1.87
EV/EBIT High	- -	0.13	7.4	-35.7	-15.05	-7.44	-3.78	-8.07	-39.1	-40.57	-6.6	-5.12	-3.43	-3.44
EV/EBIT Low	- -	0.13	7.4	-16.46	-2.91	-3.63	-0.99	-1.72	-1.76	-5.68	-1.74	-0.99	-1.27	-1.06
Last Price	- -	- -	- -	701.8	198	202.8	90.4	69	490	166.6	112	28	16.62	14.88
High Price	- -	- -	- -	1,040	719.6	348.4	227	167.8	770	598	189.8	137.4	41	29.98
Enterprise Value Average	- -	-1	-112	1,371	791	423	250	291	1,162	1,280	745	609	222	176
Enterprise Value High	- -	-1	-112	1,958	1,397	680	379	568	3,446	2,617	1,188	999	416	324
Enterprise Value Low	- -	-1	-112	903	270	332	99	121	155	366	313	194	154	100

Shares Outstanding	- -	2	2	2	2	2	2	4	5	5	6	7	9	10
Diluted Weighted Avg Shares	1	1	1	1	2	2	2	3	4	5	5	6	8	9
Basic Weighted Avg Shares	1	1	1	1	2	2	2	3	4	5	5	6	8	9
Revenue per Share	- -	- -	- -	- -	10.92	15.87	13.88	12.18	8.33	31.61	- -	- -	- -	0.09
EBITDA per Share	-2.91	-4.01	-10	-46	-44.49	-41.6	-45.37	-22.16	-20.44	-12.77	-32.07	-29.51	-14.91	-10.14
Operating Income per Share	-2.93	-4.06	-10.13	-46.62	-46.6	-45.19	-49.23	-24.85	-22.09	-14.07	-33.29	-30.48	-15.61	-10.61
Basic EPS, GAAP	-3.02	-4.69	-11.22	-46.56	-45.97	-44.19	-48.57	-24.81	-22.34	-14.3	-46.29	-17.77	0.02	0.64
Basic EPS from Cont Ops	-3.02	-4.1	-11.22	-46.56	-45.97	-44.19	-48.57	-24.81	-22.34	-14.3	-33.97	-29.71	-16.19	0.64
Diluted EPS, GAAP	-3.02	-4.69	-11.22	-46.56	-45.97	-44.19	-48.57	-24.81	-22.34	-14.3	-46.29	-17.77	0.02	0.64
Diluted EPS from Cont Ops	-3.02	-4.1	-11.22	-46.56	-45.97	-44.19	-48.57	-24.81	-22.34	-14.3	-33.97	-29.71	-16.19	0.64
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-2.83	-3.57	-6.96	-34.71	22.04	-37.34	-30.85	-27.02	-23.46	1.46	-42.34	-18.34	-19.13	0.13
Free Cash Flow per Basic Share	-3.11	-3.69	-7.63	-38.42	11.26	-39.65	-31.8	-27.37	-23.61	-0.63	-44.16	-19.58	-19.18	0.1
Cash & Equivalents per Share	- -	0.9	62.31	104.95	95.77	73.94	41.93	27.03	55.46	63.27	28.96	18.95	3.56	4.79
Book Value per Share	- -	-6.07	-14.58	105.11	65.73	29.92	-23.47	-13.78	38.21	28.62	1.72	-6.64	1.59	4.63
Tangible Book Value per Share	- -	-6.07	-14.58	105.11	65.73	29.92	-23.47	-13.78	38.21	28.62	1.72	-6.64	1.59	4.63

Seres Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)